Mr. Downey received his Master of Administration degree from Washington University in St. Louis and is a graduate from the University of Michigan in Ann Arbor. He has managed numerous business-to-business market research projects in the areas of electronics and biopharmaceutical contract manufacturing, semiconductor materials and pharmaceutical drug discovery. Mr. Downey has written extensively in “Genetic Engineering News,” “American Pharmaceutical Outsourcing,” and “Contract Pharma” on the topics of contract manufacturing, outsourcing and high throughput screening. Mr. Downey has presented at biopharmaceutical conferences in the North America, Europe, and Asia, and has moderated panel discussions with industry leaders. Mr. Downey has over 25 years of industry experience. He has held various product marketing positions in the semiconductor materials industry. In addition, Mr. Downey has provided financial leadership for both private and public companies.

Ms. Fox has a Master of Business Administration degree from the University of California at Berkeley, Haas School of Business, and is a Phi Beta Kappa graduate in the life sciences at UC Berkeley. She has conducted and managed market research projects for business-to-business biotechnology, pharmaceutical drug discovery, biopharmaceutical manufacturing, medical, and electronics products since 1988. Ms. Fox has written numerous articles for 'Genetic Engineering News' regarding biomanufacturing and drug discovery technologies, given presentations on biotechnology and electronics markets at industry conferences, and helped more than 150 clients increase sales, fine-tune their business strategies, and make successful decisions regarding high tech markets.

received her Ph.D. in biochemistry from the Sackler School of Biomedical Sciences at Tufts University, where she studied the acute regulation of adrenal steroidoidogenesis. Dr. Hartigan has worked in various areas of market research in the biotechnology field. She has extensive experience in writing proposals for grants and providing technical analysis aiding investment decisions. At HighTech Business Decisions, Jenny has led various market research studies in the areas of biopharmaceutical contract manufacturing, assay development, and high throughput screening.

received her Masters of Business Administration degree from the University of California at Berkeley, Haas School of Business. Ms. Liu has been involved with various biopharmaceutical market projects including pricing, supply and demand analysis in the biopharmaceutical contract manufacturing market. Prior to joining HighTech Business Decisions, Ms. Liu held various strategic and management positions at Intel Corporation providing market and competitive analysis to the CFO and his staff.

has a Masters of Business Administration degree from Santa Clara University, and holds a Bachelor of Science degree in Operations Research and Industrial Engineering from Cornell University. Ms. Miles has worked on CMO selection and customer satisfaction analysis for biopharmaceutical contract manufacturers.

Dr. Helen Wang Nicely received her Ph.D in cancer immunology from the University of London, England and holds a B.S. in microbiology from the University of Surrey, England. She came to California as a Visiting Scientist with Genentech to study the immunology of rheumatoid arthritis, and later continued her postdoc work as Lab Manager to the Forbes Norris ALS/MDA Lab at California Pacific Medical Center. Dr. Nicely has been co-author of many neuroscience papers and has written several analytical reports on infectious diseases, cancer immunotherapies and cancer clinical management. Recently, she has been involved in conducting market research interviews with scientists working in the field of high-throughput screening (HTS) for drug discovery. Dr. Nicely has written reports and articles on HTS for HTBD and industry trade journals.

Dr. Sopchak has a B.S. in Medical Technology and Ph.D. in Immunology and Microbiology from Wayne State University School of Medicine. She continued her studies as a postdoctoral fellow at Stanford University in Pathology and Oncology. She has held positions as visiting assistant professor at Mills College and San Francisco State University teaching immunology, microbiology and genetics. Her research interest includes the molecular basis of cancer and tumor progression. As an analyst at HighTech Business Decisions, she has conducted numerous market research studies.

Dr. Farr-Jones works with HTBD as a market research analyst in biotechnology and pharmaceutical markets. She was recently at BioCentury Publications, the leading biotechnology business newsletter, where she analyzed and wrote about strategic market and technology issues affecting biotechnology companies. Previously, she was editor of the news section of the Journal of Molecular Graphics and Modeling, covering developments in silico drug discovery. Her scientific research has included peptide and protein structure using nuclear magnetic resonance spectroscopy, protease mechanism and molecular modeling. Her education includes post-doctoral work at the University of California, San Francisco, a Ph.D. in Biochemistry from Tufts University in Boston, a B.Sc. in Chemistry from Southampton University, Southampton, England and Certificates in Marketing and Finance from the University of California, Berkeley extension.

Dr. Khoury received his Ph.D. in Organic Chemistry from the University of California, Davis and previously obtained his B.S. in Chemistry and a minor in Biology from Santa Clara University. After earning his Ph.D., he completed a post-doctoral fellowship with Nobel Laureate Jean-Marie Lehn at the Universite Louis Pasteur in Strasbourg, France. He currently is employed with Exelixis Pharmaceuticals as a Medicinal Chemist within the Drug Discovery Program. He also works as an analyst/consultant for HighTech Business Decisions and is involved in projects in the biotechnology and biopharmaceutical industry. Dr. Khoury has published more than forty articles and has written reports and articles on high-throughput screening for drug discovery and biopharmaceutical contract manufacturing for HighTech Business Decisions.

Michael Biros works with HTBD as a market research analyst in biotechnology and pharmaceutical markets. He is a principal at Celligent, an independent marketing consultancy, which is focused on providing business development, product marketing and market research services to companies developing emerging technologies that accelerate Drug Discovery. Prior to founding Celligent, Mike held positions of increasing responsibility at a range of life science research companies including Molecular Devices, LJL BioSystems, and Dionex. His focus has been strategic marketing and product management for application-driven products that address drug discovery research needs by combining microplate-based instruments, consumables, reagents and software. Since 1999, he has been the Executive Chair of the Laboratory Robotics Interest Group, Bay Area Chapter. He is an active member in the Society for Biomolecular Screening. Mike holds an undergraduate degree in Biochemistry and Cellular Biology from U.C. San Diego, and an MBA from the Leavey School of Business at Santa Clara University.

Mr. Ogden earned a Master of Business Administration degree from the University of Chicago with work completed at Stanford University. He also has a Bachelor of Science degree in Electrical and Computer Engineering from the University of Wisconsin. He was formerly the Director of Marketing for Solectron Corporation (Milpitas, CA), the world's second largest electronics contract manufacturer. He managed strategic planning, market analysis, new account targeting, and the customer satisfaction processes. Solectron won the Malcolm Baldrige National Quality Award in 1991, and since then, he has given numerous presentations on customer satisfaction to Baldrige-related groups. He was also an examiner for the California Governor's Golden State Quality Award which is identical to the Baldrige Award. Before joining Solectron, Mr. Ogden served in various strategic planning, marketing management, research, new product launch and sales positions with the Hewlett-Packard Company.

Mr. Sherman is President of New Venture Consulting and has more than 20 years' experience in marketing of high technology electronics products, as well as a background in design and development of advanced new products. He has been a founder of two startup companies and consults with many high-tech start-ups in addition to assisting various OEM firms in their product and business development strategies. He has a Bachelor of Science in Astrophysics, a Masters of Science in Electrical Engineering from the University of Colorado, and an MBA from Edinburgh School of Business, Edinburgh, Scotland. Mr. Sherman now runs New Venture Consulting, focusing on providing market research, due diligence, and business development services to clients in the electronic manufacturing services industry. He works with HighTech Business Decisions on consulting projects involving high-tech electronics manufacturing.